Technology News

Retina-AI has released Fluid Intelligence, the first artificial intelligence mobile app for eye care providers, the company announced in a press release.

The European Patent Office has revoked the MicroPulse patent held by Iridex, according to a press release from OD-OS.

At OWL, we understand that a large part of our role is simply to bring amazing people together. Through our forum, individuals, nonprofits and health care companies learn, generate ideas, build relationships and help each other grow. At the Ophthalmology Technology Summit this summer, we sat down with two of OWL’s member-partners — OCTANe and Provident Healthcare Partners — to learn what makes these investment companies unique and what they contribute to the OWL community.

OCTANe’s Ophthalmology Technology Summit, which aims to bring together ophthalmology experts and entrepreneurs to discuss technology and business opportunities, grew by 35% this year, with more than 400 people in attendance, according to a press release.

The OCTANe Ophthalmology Technology Summit took place in Newport Beach, California, on June 29, bringing together key opinion leaders in ophthalmology, industry and technology.

NEWPORT BEACH, Calif. ― James Mazzo, discusses the many topics encompassing innovation in ophthalmology covered during OCTANe’s Ophthalmology Technology Summit here.

NEWPORT BEACH, Calif. — James V. Mazzo, global president of Zeiss and chairman of the board for Neurotech, discusses why OCTANe’s Ophthalmology Technology Summit is essential for the promotion of the ophthalmology innovation hub that exists in Orange County.

NEWPORT BEACH, Calif. ― Richard L. Lindstrom, MD, chief medical editor of Ocular Surgery News, shares his perspective on OCTANe’s Ophthalmology Technology Summit.

Registration is still open for the OCTANe 2018 Ophthalmology Technology Summit, which begins Friday and brings together some of ophthalmology’s top physicians, key opinion leaders, innovators, investors and entrepreneurs.

The European Union has granted a CE mark for the LT-300 light delivery system, a treatment device for dry age-related macular degeneration, LumiThera announced in a press release.